Worth reading
37Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Deterioration
Direction inferred from the company’s description.Scale
6275000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the 39th Stock Acquisition Rights issued through a third-party allotment, with an exercise price adjustment clause
発行・処分する株式数
6,275,000 new shares (number of shares delivered from 1 August 2026)
Intended allottee
EVO FUND (allottee of the stock acquisition rights)
Existing Shares and Increase
+6.74%Rate of increase
93,101,408 shares99,376,408Shares
6.74% (6,275,000 shares ÷ 93,101,408 shares issued and outstanding as of the end of July 2026)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥21.0 or ¥22.0 (exercise prices during the period). The floor under the adjustment clause is Not disclosed
Number of Stock Acquisition Rights
Total issued: 600,000 rights; exercised from 1 August 2026: 62,750 rights; unexercised as of 31 July 2026: 430,750 rights; currently unexercised: 368,000 rights
Most recent equity financing
Timing 1 June 2026 / Type Issuance of the 39th Stock Acquisition Rights through a third-party allotment, with an exercise price adjustment clause / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the 39th Stock Acquisition Rights issued through a third-party allotment, with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | 6,275,000 new shares (number of shares delivered from 1 August 2026) |
| Intended allottee | EVO FUND (allottee of the stock acquisition rights) |
| Dilution Rate | 6.74% (6,275,000 shares ÷ 93,101,408 shares issued and outstanding as of the end of July 2026) |
| Total number of issued shares | 93,101,408 shares → 99,376,408 shares（6.74%） |
| Exercise price | ¥21.0 or ¥22.0 (exercise prices during the period). The floor under the adjustment clause is Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 600,000 rights; exercised from 1 August 2026: 62,750 rights; unexercised as of 31 July 2026: 430,750 rights; currently unexercised: 368,000 rights |
| Most recent equity financing | Timing 1 June 2026 / Type Issuance of the 39th Stock Acquisition Rights through a third-party allotment, with an exercise price adjustment clause / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the bulk exercise of these stock acquisition rights.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.